Orwin John A

Director at Travere Therapeutics, Inc. · on record since May 21, 2026
Director at CARGO Therapeutics, Inc. · on record since Nov 13, 2023
PRESIDENT & CEO at Atreca, Inc. · on record since Jun 19, 2019
Director at NeurogesX Inc · on record since Nov 23, 2009
Director at Relypsa Inc · on record since Nov 20, 2013
President & CEO at Relypsa Inc · on record since Nov 20, 2013
Director at AFFYMAX INC · on record since Feb 2, 2011
CEO at AFFYMAX INC · on record since Feb 2, 2011
Director at ANAPTYSBIO, INC · on record since Apr 22, 2026
Director at First Tracks Biotherapeutics, Inc. · on record since Apr 22, 2026
Director at ARRAY BIOPHARMA INC · on record since Nov 7, 2012
Director at SEATTLE GENETICS INC /WA · on record since Jan 14, 2014
Director at Atreca, Inc. · on record since Jun 19, 2019

Insider trading activity of Orwin John A

Transactions on record: 247; since Nov 23, 2009

Open-market buys: 4; $298.4K

Open-market sells: 30; $8.6M

Companies traded: 10; last filing Jun 17, 2026

Figures computed from official regulatory filings — methodology.

Companies where Orwin John A has traded

ANAPTYSBIO, INC30 tx · Jun 17, 2026
First Tracks Biotherapeutics, Inc.14 tx · Jun 17, 2026
Travere Therapeutics, Inc.20 tx · May 21, 2026
CARGO Therapeutics, Inc.5 tx · Aug 19, 2025
Atreca, Inc.17 tx · $122.4K · Apr 17, 2024
SEATTLE GENETICS INC /WA31 tx · $7.2M · Dec 15, 2023
ARRAY BIOPHARMA INC25 tx · $801.5K · Jul 30, 2019
Relypsa Inc47 tx · $7M · Sep 2, 2016
AFFYMAX INC53 tx · $6M · Jun 28, 2013
NeurogesX Inc

Track record of Orwin John A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Orwin John A

Co-insiders of Orwin John A

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Value · USD	Src
ANAPTYSBIO, INC	Jun 17, 2026	Exercise	6,030	—	SEC
ANAPTYSBIO, INC	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	Exercise	6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	7,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	2,500	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	AwardD	12,000	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	Award	4,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	42,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	15,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	3,311	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	8,250	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	10,600	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-16,510	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	8,250	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	10,600	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	6,030	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-8,250	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	1,300	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-10,600	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	6,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	3,311	$0	SEC

Company	Filed	Type	Qty	Value · USD	Src
ANAPTYSBIO, INC	Jun 17, 2026	Exercise	6,030	—	SEC
ANAPTYSBIO, INC	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	ExerciseD	-6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 17, 2026	Exercise	6,030	—	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	7,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Jun 12, 2026	AwardD	2,500	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	AwardD	12,000	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	Award	4,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	42,000	$0	SEC
First Tracks Biotherapeutics, Inc.	May 14, 2026	AwardD	15,000	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	3,311	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	8,250	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	10,600	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-16,510	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	8,250	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	10,600	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	6,030	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-16,510	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-8,250	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	1,300	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	OtherD	-10,600	$0	SEC
ANAPTYSBIO, INC	Apr 22, 2026	AwardD	16,510	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	6,000	$0	SEC
First Tracks Biotherapeutics, Inc.	Apr 22, 2026	AwardD	3,311	$0	SEC